ATLANTA, Feb. 21, 2012 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM) (“Alimera”), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its fourth quarter and fiscal year 2011 financial results after the market close on Thursday, March 8, 2012. An investor conference call will follow on the same day at 4:30 p.m. ET.
